Home/Filings/4/0000950170-23-049779
4//SEC Filing

Barrow Robert 4

Accession 0000950170-23-049779

CIK 0001813814other

Filed

Sep 24, 8:00 PM ET

Accepted

Sep 25, 9:30 PM ET

Size

7.2 KB

Accession

0000950170-23-049779

Insider Transaction Report

Form 4
Period: 2023-09-25
Barrow Robert
DirectorChief Executive Officer
Transactions
  • Sale

    Common Shares

    2023-09-25$3.58/sh8,231$29,467611,729 total
  • Sale

    Common Shares

    2023-09-25$3.57/sh5,268$18,807619,960 total
Footnotes (3)
  • [F1]Represents the number of Common Shares sold to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units, pursuant to sell-to-cover elections.
  • [F2]The reported price is a weighted average sales price. This represents the price in United States Dollars using the conversion rate on September 25, 2023. These shares were sold in multiple transactions on September 25, 2023 at prices ranging from $4.78 to $4.84 CAD Dollars. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The reported price is a weighted average sales price. These shares were sold in multiple transactions on September 25, 2023 at prices ranging from $3.57 to $3.60 US Dollars. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote

Documents

1 file

Issuer

Mind Medicine (MindMed) Inc.

CIK 0001813814

Entity typeother

Related Parties

1
  • filerCIK 0001897557

Filing Metadata

Form type
4
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 9:30 PM ET
Size
7.2 KB